News Highlights

India authorizes Zydus Cadila's DNA Vaccine For 12 Years & Above
India authorizes Zydus Cadila's DNA Vaccine For 12 Years & Above

India's drug regulator has given emergency use authorisation to a Covid-19 vaccine candidate developed by Zydus Cadila, making it the sixth addition to the country's inoculation programme against the pandemic.

The World Health Organization Living Guidelines
The World Health Organization Living Guidelines

Contains the organization’s most up-to-date recommendations on drugs to prevent COVID-19, Therapeutics and Clinical management of COVID19. It is updated regularly as new evidence emerges.

COVID-19 Vaccines for Immunocompromised People
COVID-19 Vaccines for Immunocompromised People

People with moderately to severely compromised immune systems are especially vulnerable to COVID-19. An additional dose intended to improve immunocompromised people’s response to their initial vaccine series.